Land: New Zealand
Språk: engelsk
Kilde: Ministry for Primary Industries
halofuginone base
Schering-Plough Animal Health Limited
halofuginone base
halofuginone base 0.5 g/litre
Coccidiostat
ACVM Registered
2008-05-27
HALOCUR 490 mL and 980 mL – Label and Label fix-a-form A009802 Page 1 of 6 HALOCUR 29 Jun 2021 Label – 490 mL, Front RESTRICTED VETERINARY MEDICINE KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY HALOCUR ® ORAL SOLUTION FOR TREATMENT OF _CRYPTOSPORIDIUM_ IN CALVES. ACTIVE CONSTITUENT: 0.5 G/L HALOFUGINONE BASE (AS LACTATE SALT). INDICATIONS For the prevention and treatment of diarrhoea caused by _Cryptosporidium parvum_. READ ENTIRE LABEL BEFORE USE. ACVM No. A009802. CONTENTS: 490 ML BATCH NO. EXPIRY DATE MSD AH logo HALOCUR 490 mL and 980 mL – Label and Label fix-a-form A009802 Page 2 of 6 HALOCUR 29 Jun 2021 Label – 490 mL, Fix-a-form (Front cover) RESTRICTED VETERINARY MEDICINE KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY HALOCUR ® WITHHOLDING PERIODS: Cattle (Meat): 28 days. NOT FOR USE IN BOBBY CALVES. WARNING. Harmful to aquatic life. Harmful if inhaled. Causes eye irritation. May cause liver/kidney damage. READ ENTIRE LABEL BEFORE USE. MSD AH logo Label – 490 mL [980 mL], Fix-a-form (Pages 2 – 6) ACTIVE CONSTITUENT: 0.5 G/L HALOFUGINONE BASE (AS LACTATE SALT). READ ENTIRE LABEL BEFORE USE. INDICATIONS In newborn calves: - For the prevention of diarrhoea caused by _Cryptosporidium parvum_, treatment should be commenced within 24-48 hours post-birth. - For the treatment of diarrhoea caused by _Cryptosporidium parvum_, treatment should be commenced within 24 hours after onset of diarrhoea. DIRECTIONS FOR USE PRECAUTIONS For ORAL administration only - DO NOT INJECT. Do not use on an empty stomach. Do not use where diarrhoea has been established for more than 24 hours and in weak animals. NOT FOR USE IN BOBBY CALVES. For treatment of anorexic calves, the product should be administered in half a litre of electrolyte solution. Calves should receive enough colostrum according to good breeding practice. SPECIAL PRECAUTIONS As symptoms of toxicity may occur at 2 times the therapeutic dose, IT IS IMPORTANT TO STRICTLY ADHERE TO THE RECOMMENDED DOSE RATE. Symptoms of toxicity include Les hele dokumentet